Arax Advisory Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
Arax Advisory Partners's ADMA Position: Q2 2026 in Review
Arax Advisory Partners increased its ADMA Biologics (ADMA) stake by 764% in Q2 2026, buying an estimated $67.5K and bringing the position to 8,377 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2998.
Arax Advisory Partners first reported a position in ADMA in Q2 2024 and has held it in 7 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Arax Advisory Partners held 8,377 shares of ADMA Biologics worth $70.1K as of Q2 2026.
- Arax Advisory Partners bought 7,408 ADMA Biologics shares in Q2 2026, an estimated $67.5K.
- ADMA Biologics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2998 holding.
- Arax Advisory Partners first reported a position in ADMA Biologics in Q2 2024 and has held it in 7 quarters since.
- 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.